Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Viyash Scientific Acquisition Worth ₹188 Cr

Viyash Scientific acquired 100% of Italy's BioForLife for ₹188 Crore. The strategic move strengthens its European companion animal health presence and global growth footprint.

Key figures
Value₹188.0 Cr
Execution periodQ2 FY27
Source

BSE filing, NSE: VIYASH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Viyash Scientific Ltd: key numbers

Share price
₹227.00
Market cap
₹10,028 Cr
Revenue (annual)
₹3,420 Cr
Net profit (annual)
₹177.3 Cr
P/E (TTM)
58.6×Sector 46.1×
Promoter holding
49.24%-12.07% QoQ
FII holding
2.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Viyash Scientific Ltd

All →

Other acquisition announcements

All →